Approval · Notice of Compliance 197 · 2002
ABELCET: Notice of Compliance 197
Issued October 15, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 197
- Date
- October 15, 2002
- Company
- Elan Pharmaceuticals, Inc.South San Francisco, California, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antifungal
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ABELCET | 02231590 | Cancelled Post Market |
Medicinal ingredients
- AMPHOTERICIN B 5 MG per ML